Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fitzgerald

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Biorxiv : the Preprint Server for Biology|April 1, 2024
"Multiplexed screen identifies a <i>Pseudomonas aeruginosa</i> -specific small molecule targeting the outer membrane protein OprH and its interaction with LPS"Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Cell Chemical Biology|December 28, 2024
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screenBradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Plos Pathogens|May 16, 2017
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulenceAmy K Barczak, Roi Avraham, Shantanu Singh, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Reply to Guy et al.: Support for a bottleneck in the 2011 Escherichia coli O104:H4 outbreak in GermanyYonatan H Grad, Marc Lipsitch, Allison D Griggs, et al.
Nature Communications|November 3, 2025
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosisAustin N Bond, Marek Orzechowski, Shuting Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignanciesEdmund C Lee, Michael Fitzgerald, Bret Bannerman, et al.
G3 (Bethesda, Md.)|September 30, 2015
Genome Sequences of Three Phytopathogenic Species of the Magnaporthaceae Family of FungiLaura H Okagaki, Cristiano C Nunes, Joshua Sailsbery, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2006
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studiesHilary Hoey, Hannah M McGee, Michael Fitzgerald, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agentQun Li, Keith W Woods, Akiyo Claiborne, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|April 1, 2024
"Multiplexed screen identifies a <i>Pseudomonas aeruginosa</i> -specific small molecule targeting the outer membrane protein OprH and its interaction with LPS"Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Cell Chemical Biology|December 28, 2024
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screenBradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Plos Pathogens|May 16, 2017
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulenceAmy K Barczak, Roi Avraham, Shantanu Singh, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Reply to Guy et al.: Support for a bottleneck in the 2011 Escherichia coli O104:H4 outbreak in GermanyYonatan H Grad, Marc Lipsitch, Allison D Griggs, et al.
Nature Communications|November 3, 2025
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosisAustin N Bond, Marek Orzechowski, Shuting Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignanciesEdmund C Lee, Michael Fitzgerald, Bret Bannerman, et al.
G3 (Bethesda, Md.)|September 30, 2015
Genome Sequences of Three Phytopathogenic Species of the Magnaporthaceae Family of FungiLaura H Okagaki, Cristiano C Nunes, Joshua Sailsbery, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2006
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studiesHilary Hoey, Hannah M McGee, Michael Fitzgerald, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agentQun Li, Keith W Woods, Akiyo Claiborne, et al.
Pageof 21